nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—HTR3A—enteric nervous system—narcolepsy	0.189	0.552	CbGeAlD
Metoclopramide—HTR4—brain—narcolepsy	0.0237	0.0694	CbGeAlD
Metoclopramide—HTR3A—brainstem—narcolepsy	0.016	0.0468	CbGeAlD
Metoclopramide—HTR3A—forebrain—narcolepsy	0.0154	0.0451	CbGeAlD
Metoclopramide—CYP17A1—medulla oblongata—narcolepsy	0.0142	0.0416	CbGeAlD
Metoclopramide—Amisulpride—HTR2A—narcolepsy	0.012	0.625	CrCbGaD
Metoclopramide—CHRM1—forebrain—narcolepsy	0.0117	0.0343	CbGeAlD
Metoclopramide—DRD2—brainstem—narcolepsy	0.00977	0.0286	CbGeAlD
Metoclopramide—DRD2—forebrain—narcolepsy	0.00943	0.0276	CbGeAlD
Metoclopramide—DRD3—brain—narcolepsy	0.00925	0.0271	CbGeAlD
Metoclopramide—CYP17A1—brain—narcolepsy	0.00815	0.0239	CbGeAlD
Metoclopramide—Cisapride—HTR2A—narcolepsy	0.00719	0.375	CrCbGaD
Metoclopramide—HTR3A—brain—narcolepsy	0.0064	0.0187	CbGeAlD
Metoclopramide—DRD2—midbrain—narcolepsy	0.00623	0.0182	CbGeAlD
Metoclopramide—CYP2D6—brainstem—narcolepsy	0.00587	0.0172	CbGeAlD
Metoclopramide—CYP2D6—forebrain—narcolepsy	0.00567	0.0166	CbGeAlD
Metoclopramide—CHRM1—brain—narcolepsy	0.00486	0.0142	CbGeAlD
Metoclopramide—DRD2—brain—narcolepsy	0.00391	0.0115	CbGeAlD
Metoclopramide—DRD2—Monoamine GPCRs—HTR2A—narcolepsy	0.00378	0.00592	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00373	0.00584	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00372	0.00582	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00372	0.00582	CbGpPWpGaD
Metoclopramide—CHRM1—Monoamine GPCRs—HTR2A—narcolepsy	0.0037	0.00579	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00354	0.00554	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00354	0.00554	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00351	0.00548	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00351	0.00548	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00349	0.00546	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—P2RY11—narcolepsy	0.00342	0.00535	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—HRH3—narcolepsy	0.00342	0.00535	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0034	0.00531	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0034	0.00531	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00339	0.0053	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—P2RY11—narcolepsy	0.00328	0.00513	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—HCRTR2—narcolepsy	0.00328	0.00512	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—HCRTR1—narcolepsy	0.00328	0.00512	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HCRTR1—narcolepsy	0.00321	0.00503	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HCRTR2—narcolepsy	0.00321	0.00503	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—HCRTR2—narcolepsy	0.00321	0.00502	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—HCRTR1—narcolepsy	0.00321	0.00502	CbGpPWpGaD
Metoclopramide—DRD2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00318	0.00497	CbGpPWpGaD
Metoclopramide—CHRM1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00311	0.00487	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—P2RY11—narcolepsy	0.0031	0.00486	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00304	0.00475	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00304	0.00475	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.003	0.0047	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.003	0.0047	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00294	0.00461	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00293	0.00459	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HCRT—narcolepsy	0.00291	0.00455	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0029	0.00454	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00286	0.00447	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—TAC1—narcolepsy	0.00283	0.00443	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—NPS—narcolepsy	0.00283	0.00443	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—HCRT—narcolepsy	0.00279	0.00436	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—PENK—narcolepsy	0.00277	0.00433	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00268	0.0042	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00268	0.0042	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HCRT—narcolepsy	0.00264	0.00413	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00263	0.00411	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00263	0.00411	CbGpPWpGaD
Metoclopramide—HTR4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00261	0.00409	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00259	0.00405	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—PENK—narcolepsy	0.00259	0.00405	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00254	0.00397	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00254	0.00397	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00249	0.0039	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00247	0.00386	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00237	0.00371	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—PENK—narcolepsy	0.00235	0.00368	CbGpPWpGaD
Metoclopramide—CYP2D6—brain—narcolepsy	0.00235	0.00689	CbGeAlD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0023	0.0036	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0023	0.0036	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HCRTR2—narcolepsy	0.00229	0.00358	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HCRTR1—narcolepsy	0.00229	0.00358	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00225	0.00352	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00225	0.00352	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00224	0.0035	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00222	0.00347	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—P2RY11—narcolepsy	0.00221	0.00346	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—TRH—narcolepsy	0.0022	0.00345	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0022	0.00344	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Other—HTR2A—narcolepsy	0.0022	0.00343	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00217	0.0034	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—PENK—narcolepsy	0.00212	0.00331	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00211	0.00331	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—HRH3—narcolepsy	0.00206	0.00323	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—TRH—narcolepsy	0.002	0.00313	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—NPS—narcolepsy	0.00194	0.00303	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HRH3—narcolepsy	0.00193	0.00302	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CHKB—narcolepsy	0.00193	0.00302	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00191	0.00299	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HCRTR2—narcolepsy	0.0019	0.00297	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HCRTR1—narcolepsy	0.0019	0.00297	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00189	0.00296	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00189	0.00295	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HCRT—narcolepsy	0.00188	0.00294	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00187	0.00292	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00185	0.00289	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—P2RY11—narcolepsy	0.00183	0.00287	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HRH3—narcolepsy	0.00175	0.00274	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.00175	0.00274	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.00175	0.00274	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00171	0.00268	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00171	0.00268	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—HTR2A—narcolepsy	0.0017	0.00267	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.00169	0.00264	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00168	0.00263	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—PENK—narcolepsy	0.00167	0.00262	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CHKB—narcolepsy	0.00166	0.0026	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00165	0.00259	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00165	0.00258	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00164	0.00256	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—NPS—narcolepsy	0.0016	0.0025	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—TAC1—narcolepsy	0.0016	0.0025	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.00158	0.00247	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HCRT—narcolepsy	0.00156	0.00244	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CHKB—narcolepsy	0.00155	0.00243	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00154	0.0024	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00154	0.0024	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.00148	0.00232	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00146	0.00229	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—NPS—narcolepsy	0.00145	0.00227	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—TAC1—narcolepsy	0.00145	0.00227	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00145	0.00227	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.00144	0.00225	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00143	0.00224	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00143	0.00224	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—TRH—narcolepsy	0.00142	0.00223	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00141	0.0022	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0014	0.00219	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PENK—narcolepsy	0.00139	0.00217	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00137	0.00215	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00137	0.00215	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00136	0.00212	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00136	0.00212	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CPT1B—narcolepsy	0.00131	0.00205	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00129	0.00202	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00129	0.00202	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—PENK—narcolepsy	0.00128	0.002	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00125	0.00196	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00125	0.00196	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—P2RY11—narcolepsy	0.00125	0.00195	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HRH3—narcolepsy	0.00125	0.00195	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00123	0.00192	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00123	0.00192	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TRH—narcolepsy	0.00118	0.00185	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HCRTR2—narcolepsy	0.00117	0.00184	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HCRTR1—narcolepsy	0.00117	0.00184	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—P2RY11—narcolepsy	0.00113	0.00177	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CPT1B—narcolepsy	0.00113	0.00177	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—TRH—narcolepsy	0.00109	0.0017	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00107	0.00167	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HCRT—narcolepsy	0.00106	0.00166	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CPT1B—narcolepsy	0.00106	0.00165	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00104	0.00163	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00104	0.00163	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HRH3—narcolepsy	0.00104	0.00162	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—TAC1—narcolepsy	0.00103	0.00162	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—NPS—narcolepsy	0.00103	0.00162	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00102	0.00159	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00102	0.00159	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000989	0.00155	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000989	0.00155	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000968	0.00151	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000968	0.00151	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HCRT—narcolepsy	0.000964	0.00151	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HTR2A—narcolepsy	0.000963	0.00151	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000955	0.00149	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000955	0.00149	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000954	0.00149	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PENK—narcolepsy	0.000946	0.00148	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.000935	0.00146	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.000935	0.00146	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.000924	0.00145	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.000898	0.00141	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.000898	0.00141	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.000879	0.00138	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.000879	0.00138	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HTR2A—narcolepsy	0.000874	0.00137	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000868	0.00136	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PENK—narcolepsy	0.000859	0.00134	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TAC1—narcolepsy	0.000859	0.00134	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NPS—narcolepsy	0.000859	0.00134	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.000849	0.00133	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000826	0.00129	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000817	0.00128	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000812	0.00127	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TRH—narcolepsy	0.000804	0.00126	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.000795	0.00124	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000791	0.00124	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000791	0.00124	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.000775	0.00121	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.000775	0.00121	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.000738	0.00115	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TRH—narcolepsy	0.000731	0.00114	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00073	0.00114	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.000724	0.00113	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.000722	0.00113	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000714	0.00112	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.000709	0.00111	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HRH3—narcolepsy	0.000705	0.0011	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HCRTR2—narcolepsy	0.000693	0.00108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HCRTR1—narcolepsy	0.000693	0.00108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—P2RY11—narcolepsy	0.00067	0.00105	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000657	0.00103	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.000643	0.00101	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HRH3—narcolepsy	0.000641	0.001	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000625	0.000978	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR2A—narcolepsy	0.000622	0.000973	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.000616	0.000963	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000612	0.000957	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.000602	0.000942	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TAC1—narcolepsy	0.000585	0.000914	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—NPS—narcolepsy	0.000585	0.000914	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HCRT—narcolepsy	0.000569	0.000891	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000559	0.000875	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000547	0.000856	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.00054	0.000844	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TAC1—narcolepsy	0.000531	0.00083	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—NPS—narcolepsy	0.000531	0.00083	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000531	0.00083	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000531	0.00083	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000528	0.000826	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000519	0.000812	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000519	0.000812	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2A—narcolepsy	0.000517	0.000808	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.000512	0.000802	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PENK—narcolepsy	0.000508	0.000794	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000502	0.000785	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HRH3—narcolepsy	0.00049	0.000767	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.00048	0.00075	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2A—narcolepsy	0.000476	0.000745	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000466	0.000729	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—NPS—narcolepsy	0.000447	0.0007	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TAC1—narcolepsy	0.000447	0.0007	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000438	0.000685	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000438	0.000685	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HCRT—narcolepsy	0.000436	0.000682	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TRH—narcolepsy	0.000432	0.000675	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000426	0.000667	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CHKB—narcolepsy	0.00042	0.000658	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TAC1—narcolepsy	0.000406	0.000635	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—NPS—narcolepsy	0.000406	0.000635	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000398	0.000622	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000398	0.000622	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PENK—narcolepsy	0.000388	0.000608	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00038	0.000595	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HRH3—narcolepsy	0.000378	0.000592	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—narcolepsy	0.000352	0.00055	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TRH—narcolepsy	0.00033	0.000517	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000323	0.000506	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—narcolepsy	0.000319	0.0005	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPS—narcolepsy	0.000314	0.000491	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TAC1—narcolepsy	0.000314	0.000491	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HRH3—narcolepsy	0.00029	0.000453	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000286	0.000447	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000283	0.000443	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	0.000269	0.000421	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000263	0.000412	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—narcolepsy	0.000244	0.000382	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPS—narcolepsy	0.00024	0.000375	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TAC1—narcolepsy	0.00024	0.000375	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000239	0.000374	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000235	0.000367	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000235	0.000367	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—narcolepsy	0.000189	0.000295	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—narcolepsy	0.000144	0.000226	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000141	0.000221	CbGpPWpGaD
